Serological surveillance reveals 23.3% global pooled pertussis seropositivity and 3.6% recent infection rate across 37 countries
This systematic review and meta-analysis assessed serological surveillance data for pertussis across 37 countries involving approximately 87,000 participants. The primary outcomes included global pooled seropositivity rates and recent infection rates derived from PT-IgG or recent pertussis infection data.
The global pooled seropositivity rate was 23.3% (95% CI: 17.2–30.1%). The recent infection rate was 3.6% (95% CI: 2.4–5.0%). Seropositivity varied by age group, with 25.8% in infants aged 1–2 years, 26.2% in adolescents aged 10–19 years, 17.1% in adults aged 20–39 years, and 20.5% in individuals aged 40 years or older.
Regional differences were substantial, with seropositivity at 51.2% in the Americas and a recent infection rate of 10.3% in the Eastern Mediterranean Region. Temporal trends showed seropositivity rising from 18.0% (2011–2015) to 25.9% (2016–2022), while recent infection rates declined from 6.4% (2011–2015) to 2.7% (2016–2022).
The authors note that revealed age- and regional disparities underscore the need to advance pertussis control from childhood immunization toward a precision public health model informed by seroepidemiological data. Safety data and adverse events were not reported.